News

Stanford Medicine researchers have developed a blood test capable of detecting cancers, the ways cancer resists treatments ...
In recent years, cell therapies have developed alongside chemotherapy and immunotherapy to become a new pillar in the treatment of patients with blood and lymph gland cancer. In solid tumors, such as ...
The protein-like polymer, or PLP, platform is made from a polymer that mimics Nrf2. Once injected intravenously, it finds ...
This new CHIPS platform provides a crucial technological bridge between foundational FRESH™ 3D bioprinting capabilities and FluidForm Bio’s therapeutic mission—to create vascularized tissue constructs ...
What is Testosterone Therapy (TRT) and Why Is It Important in Northern Ireland? Testosterone Replacement Therapy (TRT) i ...
Longevity clinics, which exploded across the U.S. in the early 2020s, offer specialty treatments and personalized medical ...
The issuance of this patent marks another key milestone as FluidForm Bio continues to build a strong and defensible IP portfolio and extend its leadership in bioprinted regenerative medicine. The ...
A Houston gym owner and fitness instructor struggled with severe neck and back pain. Traditional treatments failed, leading her to stem cell therapy using umbilical cord cells.
When even one tiny section of a person’s genetic code becomes mutated or modified, cells can begin to act out of ...
Neural stem cells (NSCs) possess pluripotent characteristics, proliferative capacity, and the ability to self-renew. In the context of neurological diseases, transplantation of NSCs has been shown to ...
FluidForm Bioâ„¢, a leader in cell therapies for chronic diseases such as type 1 diabetes, today announced a major advancement in vascularized tissue engineering. A newly published study in ACS ...